Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retention and Other Efficacy Outcomes With Long-Acting Injectable Buprenorphine (Buvidal<sup>®</sup>) in France: A National Retrospective Cross-Sectional Study (OPALE 2).

Substance use & addiction journal·2026
Same author

Efficacy and safety of transcranial direct current stimulation in alcohol use disorder: A randomized controlled triple-blind trial.

Addiction (Abingdon, England)·2026
Same author

Co-occurring psychiatric disorders are key determinants of disability in alcohol use disorder: a cross-sectional analysis in 157 recently detoxified patients.

Alcohol and alcoholism (Oxford, Oxfordshire)·2026
Same author

The hidden burden of narcolepsy type 1: Discordance in psychobehavioral symptoms between patient self-reports and reports from close family members and friends.

Sleep medicine·2026
Same author

Structural brain effects of alcohol use patterns in alcohol use disorder: A systematic review and Meta-analysis.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

The rising wave of cathinone use in people attending harm reduction facilities: a French repeated cross-sectional study (2019-2023).

Addiction science & clinical practice·2026

Related Experiment Video

Updated: May 21, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

[Current data on methamphetamine].

Olivier Cottencin1, Benjamin Rolland, Dewi Guardia

  • 1UDSL, EA4559. olivier.cottencin@chru-lille.fr

La Revue Du Praticien
|June 27, 2012
PubMed
Summary
This summary is machine-generated.

Methamphetamine addiction poses a significant public health challenge, causing severe physical, mental, and cognitive issues. Integrated treatment combining psychotherapy with emerging pharmacological therapies is crucial for managing this stimulant use disorder.

More Related Videos

Neurotoxicity Assessment in Adult Danio rerio using a Battery of Behavioral Tests in a Single Tank
08:36

Neurotoxicity Assessment in Adult Danio rerio using a Battery of Behavioral Tests in a Single Tank

Published on: November 3, 2023

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
07:30

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry

Published on: November 21, 2012

Related Experiment Videos

Last Updated: May 21, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

Neurotoxicity Assessment in Adult Danio rerio using a Battery of Behavioral Tests in a Single Tank
08:36

Neurotoxicity Assessment in Adult Danio rerio using a Battery of Behavioral Tests in a Single Tank

Published on: November 3, 2023

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
07:30

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry

Published on: November 21, 2012

Area of Science:

  • Neuroscience
  • Public Health
  • Pharmacology

Background:

  • Methamphetamine is a potent psychostimulant with widespread illicit use, particularly in North America, Asia, and Eastern Europe.
  • Its use leads to severe somatic, psychiatric, and cognitive complications, including cardiovascular, pulmonary, neurological, and dental diseases.
  • Neurotoxicity contributes to cognitive impairment, acute psychosis, depression, and suicidal behavior.

Purpose of the Study:

  • To review the health complications associated with methamphetamine addiction.
  • To explore current and potential therapeutic strategies for methamphetamine use disorder.
  • To emphasize the need for integrated treatment approaches.

Main Methods:

  • Literature review of studies on methamphetamine effects and treatments.
  • Analysis of pharmacological interventions and their efficacy.
  • Assessment of the role of psychotherapy in addiction management.

Main Results:

  • Methamphetamine causes significant cardiovascular, pulmonary, neurological, and dental issues due to its vasoconstrictive properties.
  • Neurotoxicity results in cognitive deficits, psychosis, depression, and increased suicide risk.
  • No specific pharmacological cure exists, but naltrexone, modafinil, and bupropion show promise.

Conclusions:

  • Effective treatment requires a comprehensive approach integrating management of physical and psychiatric complications with addiction treatment.
  • Dopamine agonists like dextroamphetamine and methylphenidate are considered potential replacement therapies.
  • Psychotherapy is essential and should complement pharmacological interventions for a combined treatment strategy.